COP1 Deficiency in BRAF<sup>V600E</sup> Melanomas Confers Resistance to Inhibitors of the MAPK Pathway
Aberrant activation of the mitogen-activated protein kinase (MAPK) cascade promotes oncogenic transcriptomes. Despite efforts to inhibit oncogenic kinases, such as BRAFV600E, tumor responses in patients can be heterogeneous and limited by drug resistance mechanisms. Here, we describe patient tumors...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2025-06-01
|
| סדרה: | Cells |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2073-4409/14/13/975 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
